应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00399 领航医药生物科技
休市中 07-11 16:08:03
0.250
+0.006
+2.46%
最高
0.270
最低
0.244
成交量
2,949万
今开
0.250
昨收
0.244
日振幅
10.66%
总市值
4.62亿
流通市值
4.62亿
总股本
18.46亿
成交额
751.34万
换手率
1.60%
流通股本
18.46亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
领航医药生物科技07月03日遭主力抛售25万元
市场透视 · 07-03
领航医药生物科技07月03日遭主力抛售25万元
领航医药生物科技(00399)拟更名为“星太链集团有限公司”及增加法定股本
智通财经 · 07-02
领航医药生物科技(00399)拟更名为“星太链集团有限公司”及增加法定股本
港股异动 | 领航医药生物科技(00399)一度飙升近240% 潜在收购区块链技术资产
智通财经 · 07-02
港股异动 | 领航医药生物科技(00399)一度飙升近240% 潜在收购区块链技术资产
领航医药生物科技(00399)发布年度业绩,股东应占亏损3.46亿港元
智通财经网 · 06-30
领航医药生物科技(00399)发布年度业绩,股东应占亏损3.46亿港元
领航医药生物科技拟收购Conflux资产
格隆汇 · 06-30
领航医药生物科技拟收购Conflux资产
领航医药生物科技(00399)6月23日发行普通股2355.5万股
智通财经 · 06-24
领航医药生物科技(00399)6月23日发行普通股2355.5万股
领航医药生物科技06月13日主力净流出14.6万元 散户资金买入
市场透视 · 06-13
领航医药生物科技06月13日主力净流出14.6万元 散户资金买入
领航医药生物科技(00399)拟折让约19.63%发行1.376亿股认购股份 净筹约2391.76万港元
智通财经 · 05-30
领航医药生物科技(00399)拟折让约19.63%发行1.376亿股认购股份 净筹约2391.76万港元
领航医药生物科技拟折让约17.84%配股,最高净筹约3552万港元
智通财经 · 05-29
领航医药生物科技拟折让约17.84%配股,最高净筹约3552万港元
领航医药生物科技拟折让约17.84%配售最多2.06亿股 净筹3552万港元
格隆汇 · 05-29
领航医药生物科技拟折让约17.84%配售最多2.06亿股 净筹3552万港元
领航医药生物科技05月22日主力净流入25.7万元 散户资金抛售
市场透视 · 05-22
领航医药生物科技05月22日主力净流入25.7万元 散户资金抛售
领航医药生物科技与Conflux订立谅解备忘录
格隆汇 · 05-06
领航医药生物科技与Conflux订立谅解备忘录
领航医药生物科技(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作
智通财经 · 05-06
领航医药生物科技(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作
领航医药生物科技拟扩充业务至区块链技术
格隆汇 · 04-25
领航医药生物科技拟扩充业务至区块链技术
领航医药生物科技(00399)拟扩充业务至区块链技术,进军数码创新行业
智通财经 · 04-25
领航医药生物科技(00399)拟扩充业务至区块链技术,进军数码创新行业
领航医药生物科技建议委任永拓富信会计师事务所为新任核数师
新浪港股 · 03-10
领航医药生物科技建议委任永拓富信会计师事务所为新任核数师
领航医药生物科技(00399):郑德耀辞任执行董事
智通财经 · 03-04
领航医药生物科技(00399):郑德耀辞任执行董事
领航医药生物科技盘中异动 临近收盘股价大涨5.98%
市场透视 · 02-14
领航医药生物科技盘中异动 临近收盘股价大涨5.98%
领航医药生物科技(00399):李杰鸿及齐淑娟获委任为执行董事
智通财经 · 02-11
领航医药生物科技(00399):李杰鸿及齐淑娟获委任为执行董事
加载更多
公司概况
公司名称:
领航医药生物科技
所属市场:
SEHK
上市日期:
--
主营业务:
领航医药及生物科技有限公司是一家主要从事医药及生物科技业务的香港投资控股公司。该公司通过五大分部运营。基因测试服务分部在中国及香港提供基因测试服务。生物产业产品分部在中国分销生物产业产品。美容设备及产品贸易分部在香港从事美容设备及产品贸易。证券投资分部在香港及香港境外从事证券投资。研发分部从事口服胰岛素产品的研发及商品化。
发行价格:
--
{"stockData":{"symbol":"00399","market":"HK","secType":"STK","nameCN":"领航医药生物科技","latestPrice":0.25,"timestamp":1752221283024,"preClose":0.244,"halted":0,"volume":29490000,"delay":0,"floatShares":1846000000,"shares":1846000000,"eps":-0.200113,"marketStatus":"休市中","change":0.006,"latestTime":"07-11 16:08:03","open":0.25,"high":0.27,"low":0.244,"amount":7513440,"amplitude":0.106557,"askPrice":0.255,"askSize":880000,"bidPrice":0.25,"bidSize":90000,"shortable":0,"etf":0,"ttmEps":-0.200113,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":7,"adr":0,"listingDate":966960000000,"exchange":"SEHK","adjPreClose":0.244,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":2.2077947357540784,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00399","defaultTab":"news","newsList":[{"id":"2548870226","title":"领航医药生物科技07月03日遭主力抛售25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548870226","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548870226?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530552,"startTime":"0","endTime":"0","summary":"07月03日, 领航医药生物科技股价跌3.85%,报收0.25元,成交金额400.5万元,换手率0.86%,振幅16.92%,量比0.70。领航医药生物科技今日主力资金净流出25万元,上一交易日主力净流出193.4万元。该股近5个交易日上涨27.55%,主力资金累计净流出218.4万元;近20日主力资金累计净流出216.9万元,其中净流出天数为3日。该股主力净额占比0.05%,港股市场排名2551/2670。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170751a4ccfea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170751a4ccfea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2548894917","title":"领航医药生物科技(00399)拟更名为“星太链集团有限公司”及增加法定股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2548894917","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548894917?lang=zh_cn&edition=full","pubTime":"2025-07-02 20:22","pubTimestamp":1751458952,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)发布公告,董事会建议:将公司的英文名称由“Innovative Pharmaceutical Biotech Limited”更改为“Starcoin Group Limited”,并采纳中文名称“星太链集团有限公司”为公司的第二名称,以取代现有名称“领航医药及生物科技有限公司”;及将公司的法定股本由5亿港元(分为500亿股股份)增加至12亿港元(分为1200亿股股份)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1124","00399"],"gpt_icon":0},{"id":"2548509830","title":"港股异动 | 领航医药生物科技(00399)一度飙升近240% 潜在收购区块链技术资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2548509830","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548509830?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:06","pubTimestamp":1751421973,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,领航医药生物科技今早放量大升,盘初一度飙涨近2.4倍,随后涨幅逐步收窄。截至发稿,涨67.48%,报0.345港元,成交额1941.78万港元。消息面上,领航医药生物科技公布,6月30日,公司已与卖方及Conflux订立谅解备忘录,内容有关收购目标公司全部股权的潜在收购事项,前提为目标公司按照与公司的协议完成收购Conflux 资产。Conflux为一间于中国香港注册成立的有限公司,主要从事开发区块链技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 领航医药生物科技(00399)一度飙升近240% 潜在收购区块链技术资产","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2548019898","title":"领航医药生物科技(00399)发布年度业绩,股东应占亏损3.46亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548019898","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548019898?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:12","pubTimestamp":1751299946,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)发布截至2025年3月31日止年度业绩,收益209.1 万港元,同比下降68.3%;公司拥有人应占亏损3.46亿港元,上年同期溢利1.03亿港元;每股基本亏损20.01港仙。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"领航医药生物科技(00399)发布年度业绩,股东应占亏损3.46亿港元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2547013672","title":"领航医药生物科技拟收购Conflux资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2547013672","media":"格隆汇","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547013672?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:54","pubTimestamp":1751295240,"startTime":"0","endTime":"0","summary":"格隆汇6月30日丨领航医药生物科技宣布,于2025年6月30日,公司已与卖方及Conflux订立谅解备忘录,内容有关收购目标公司全部股权的潜在收购事项,前提为目标公司按照与公司的协议完成收购Conflux资产。Conflux为一间于香港注册成立的有限公司,主要从事开发区块链技术。于本公告日期,执行董事伍鸣博士亦为Conflux的董事及Conflux的唯一最终实益拥有人。订立谅解备忘录表明公司致力透过潜在收购事项进军数码创新行业,以发展此新业务分部。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630225654a4c6e896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2545281299","title":"领航医药生物科技(00399)6月23日发行普通股2355.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2545281299","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545281299?lang=zh_cn&edition=full","pubTime":"2025-06-24 19:32","pubTimestamp":1750764724,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)发布公告,根据公司于2025年5月29日公告的配售协议,于2025年6月23日发行普通股2355.5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1309101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2543500766","title":"领航医药生物科技06月13日主力净流出14.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2543500766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543500766?lang=zh_cn&edition=full","pubTime":"2025-06-13 16:15","pubTimestamp":1749802559,"startTime":"0","endTime":"0","summary":"06月13日, 领航医药生物科技股价跌3.30%,报收0.20元,成交金额64.8万元,换手率0.17%,振幅4.72%,量比1.90。领航医药生物科技今日主力资金净流出14.6万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.38%,主力资金累计净流出14.6万元;近20日主力资金累计净流入44.1万元,其中净流入天数为4日。该股主力净额占比0.04%,港股市场排名2454/2656。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613173806a70733de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613173806a70733de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2539759322","title":"领航医药生物科技(00399)拟折让约19.63%发行1.376亿股认购股份 净筹约2391.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539759322","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539759322?lang=zh_cn&edition=full","pubTime":"2025-05-30 22:45","pubTimestamp":1748616337,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)公布,于2025年5月30日,该公司拟向Erick Wong发行1.376亿股股份,认购价每股认购股份0.176港元,较2025年5月30日收市价每股0.219港元折让约19.63%。净筹约2391.76万港元,拟用于集团的一般营运资金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2539692852","title":"领航医药生物科技拟折让约17.84%配股,最高净筹约3552万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539692852","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539692852?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:35","pubTimestamp":1748529357,"startTime":"0","endTime":"0","summary":"智通财经APP讯,$领航医药生物科技(00399)$(00399)发布公告,于2025年5月29日,公司拟配售最多2.064亿股,占经配发及发行所有配售股份扩大的公司已发行股本约10.17%。 每股配售股份0.175港元的配售价较5月29日收市价每股0.213港元折让约17.84%。假设所有配售股份获悉数配售,配售事项所得款项总额将约为3612万港元。所得款项净额估计约为3552万港元。公司拟将配售事项所得款项净额全数用作集团的一般营运资金。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2539269911","title":"领航医药生物科技拟折让约17.84%配售最多2.06亿股 净筹3552万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539269911","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539269911?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:21","pubTimestamp":1748528460,"startTime":"0","endTime":"0","summary":"格隆汇5月29日丨领航医药生物科技公告,于2025年5月29日,公司与配售代理订立配售协议,据此,配售代理已有条件同意担任公司代理,以竭诚促使目前预期不少于六名承配人按每股配售股份0.175港元的配售价认购最多206,400,000股配售股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529222421a4917a49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529222421a4917a49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1124","00399"],"gpt_icon":0},{"id":"2537914741","title":"领航医药生物科技05月22日主力净流入25.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2537914741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537914741?lang=zh_cn&edition=full","pubTime":"2025-05-22 16:15","pubTimestamp":1747901718,"startTime":"0","endTime":"0","summary":"05月22日, 领航医药生物科技股价涨3.94%,报收0.21元,成交金额95.9万元,换手率0.25%,振幅5.42%,量比0.91。领航医药生物科技今日主力资金净流入25.7万元,上一交易日主力净流出0万元。该股近5个交易日上涨6.09%,主力资金累计净流入38.5万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入38.5万元,其中净流入天数为3日。该股主力净额占比0.07%,港股市场排名91/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522172531a6e8a4c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522172531a6e8a4c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1124","00399"],"gpt_icon":0},{"id":"2533360716","title":"领航医药生物科技与Conflux订立谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=2533360716","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533360716?lang=zh_cn&edition=full","pubTime":"2025-05-06 20:43","pubTimestamp":1746535432,"startTime":"0","endTime":"0","summary":"格隆汇5月6日丨领航医药生物科技(00399.HK)公告,于2025年5月6日,公司已与Conflux订立谅解备忘录,内容有关公司有意就Conflux区块链的相关基础设施及共通关键技术与Conflux深入合作,包括但不限于创新技术研发、应用场景探索及潜在股权合作。Conflux为一间于香港注册成立的有限公司,主要从事区块链技术开发。订立谅解备忘录体现了公司通过与Conflux的潜在合作开发此新业务板块,努力进军数码创新行业。公司预期与Conflux展开长期合作,此举不仅将有助于多元化集团的业务,亦将为集团带来新利润增长点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062043529750b4a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062043529750b4a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2533463325","title":"领航医药生物科技(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2533463325","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533463325?lang=zh_cn&edition=full","pubTime":"2025-05-06 20:41","pubTimestamp":1746535272,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)公布,于2025年5月6日,公司已与 Conflux订立谅解备忘录,内容有关公司有意就Conflux区块链的相关基础设施及共通关键技术与Conflux深入合作,包括但不限于创新技术研发、应用场景探索及潜在股权合作。公告称,订立谅解备忘录体现了公司通过与Conflux的潜在合作开发此新业务板块,努力进军数码创新行业。公司预期与Conflux展开长期合作,此举不仅将有助于多元化集团的业务,亦将为集团带来新利润增长点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2530135670","title":"领航医药生物科技拟扩充业务至区块链技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2530135670","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530135670?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:07","pubTimestamp":1745586421,"startTime":"0","endTime":"0","summary":"格隆汇4月25日丨领航医药生物科技公告,公司拟扩充业务至区块链技术,进军数码创新行业。集团将启动研究开发项目,集中于区块链的相关基础设施及共通关键技术,目标为提升多类数码及商业交易的透明度、安全性及效率。此计划乃为将集团定位在创新技术应用的前端,并开发新业务模型及收益来源。集团将成立专门技术团队,凭藉与领先区块链平台及学术机构的合作伙伴关系,带头进行研究及开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2530138291","title":"领航医药生物科技(00399)拟扩充业务至区块链技术,进军数码创新行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2530138291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530138291?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:49","pubTimestamp":1745585394,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技 发布公告,本公司拟扩充业务至区块链技术,进军数码创新行业。本集团将启动研究开发项目,集中于区块链的相关基础设施及共通关键技术,目标为提升多类数码及商业交易的透明度、安全性及效率。本集团将成立专门技术团队,凭藉与领先区块链平台及学术机构的合作伙伴关系,带头进行研究及开发。本公司将保持灵活性及积极回应,以适应不断变化的情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2518930230","title":"领航医药生物科技建议委任永拓富信会计师事务所为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2518930230","media":"新浪港股","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518930230?lang=zh_cn&edition=full","pubTime":"2025-03-10 08:35","pubTimestamp":1741566900,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 领航医药生物科技(00399)发布公告,经参考公司审核委员会的推荐建议,其已议决建议委任永拓富信会计师事务所有限公司为公司新任核数师,并担任公司核数师直至公司下届股东周年大会结束为止,但须待公司股东于公司将举行的股东特别大会上批准后,方可作实。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-10/doc-inepcnct9925823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1124","00399"],"gpt_icon":0},{"id":"2516675088","title":"领航医药生物科技(00399):郑德耀辞任执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675088","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516675088?lang=zh_cn&edition=full","pubTime":"2025-03-04 21:06","pubTimestamp":1741093576,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)发布公告,郑德耀先生已辞任执行董事,自2025年3月4日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0},{"id":"2511656785","title":"领航医药生物科技盘中异动 临近收盘股价大涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511656785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511656785?lang=zh_cn&edition=full","pubTime":"2025-02-14 15:53","pubTimestamp":1739519616,"startTime":"0","endTime":"0","summary":"2025年02月14日临近收盘15时53分,领航医药生物科技股票出现异动,股价快速上涨5.98%。领航医药生物科技股票所在的个人护理行业中,整体涨幅为0.46%。其相关个股中,日光控股、领航医药生物科技、恒安国际涨幅较大,振幅较大的相关个股有领航医药生物科技、霸王集团、H&H国际控股,振幅分别为4.89%、4.65%、3.25%。领航医药生物科技公司简介:领航医药及生物科技有限公司是一家主要从事医药及生物科技业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141553369622ad4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141553369622ad4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1124","00399"],"gpt_icon":0},{"id":"2510386797","title":"领航医药生物科技(00399):李杰鸿及齐淑娟获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2510386797","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510386797?lang=zh_cn&edition=full","pubTime":"2025-02-11 21:18","pubTimestamp":1739279887,"startTime":"0","endTime":"0","summary":"智通财经APP讯,领航医药生物科技(00399)发布公告,自2025年2月11日起,邬燕敏女士已辞任非执行董事;肖焱女士已辞任非执行董事;李杰鸿先生已获委任为执行董事;齐淑娟女士已获委任为执行董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00399","BK1124"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ipb.asia","stockEarnings":[{"period":"1week","weight":0.0965},{"period":"1month","weight":0.1682},{"period":"3month","weight":0.5152},{"period":"6month","weight":0.1364},{"period":"1year","weight":0.0965},{"period":"ytd","weight":0.2019}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"领航医药及生物科技有限公司是一家主要从事医药及生物科技业务的香港投资控股公司。该公司通过五大分部运营。基因测试服务分部在中国及香港提供基因测试服务。生物产业产品分部在中国分销生物产业产品。美容设备及产品贸易分部在香港从事美容设备及产品贸易。证券投资分部在香港及香港境外从事证券投资。研发分部从事口服胰岛素产品的研发及商品化。","yearOnYearQuotes":[{"month":1,"riseRate":0.32,"avgChangeRate":-0.014808},{"month":2,"riseRate":0.48,"avgChangeRate":0.02507},{"month":3,"riseRate":0.375,"avgChangeRate":0.040308},{"month":4,"riseRate":0.4,"avgChangeRate":0.01611},{"month":5,"riseRate":0.28,"avgChangeRate":-0.00179},{"month":6,"riseRate":0.24,"avgChangeRate":-0.069659},{"month":7,"riseRate":0.2,"avgChangeRate":-0.060233},{"month":8,"riseRate":0.375,"avgChangeRate":0.020896},{"month":9,"riseRate":0.36,"avgChangeRate":-0.000597},{"month":10,"riseRate":0.36,"avgChangeRate":0.042449},{"month":11,"riseRate":0.44,"avgChangeRate":0.057192},{"month":12,"riseRate":0.36,"avgChangeRate":-0.01432}],"exchange":"SEHK","name":"领航医药生物科技","nameEN":"INNOVATIVE PHAR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"领航医药生物科技(00399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供领航医药生物科技(00399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"领航医药生物科技,00399,领航医药生物科技股票,领航医药生物科技股票老虎,领航医药生物科技股票老虎国际,领航医药生物科技行情,领航医药生物科技股票行情,领航医药生物科技股价,领航医药生物科技股市,领航医药生物科技股票价格,领航医药生物科技股票交易,领航医药生物科技股票购买,领航医药生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"领航医药生物科技(00399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供领航医药生物科技(00399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}